IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer's Disease.

Autor: Handels R; Alzheimer Centre Limburg, Faculty of Health Medicine and Life Sciences, School for Mental Health and Neuroscience, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden. Electronic address: ron.handels@maastrichtuniversity.nl., Herring WL; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden; Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA., Kamgar F; Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA., Aye S; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden., Tate A; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden., Green C; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden; Biogen Idec Ltd, Maidenhead, England, UK., Gustavsson A; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden; Quantify Research, Stockholm, Sweden., Wimo A; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden., Winblad B; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden; Theme Inflammation and Aging, Karolinska University Hospital, Huddinge, Sweden., Sköldunger A; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden., Raket LL; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden., Stellick CB; Community Health Sciences & O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada., Spackman E; Community Health Sciences & O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada., Hlávka J; Health Economics, Policy and Innovation Institute, Masaryk University, Brno, Czech Republic; USC Price School of Public Policy and Schaeffer Center for Health Policy and Economics, Los Angeles, CA, USA., Wei Y; USC Price School of Public Policy and Schaeffer Center for Health Policy and Economics, Los Angeles, CA, USA., Mar J; Basque Health Service (Osakidetza), Debagoiena Integrated Healthcare Organisation, Research Unit, Arrasate-Mondragón, Spain; Biogipuzkoa Health Research Institute, Donostia-San Sebastián, Spain; Biosistemak Institute for Health Service Research, Barakaldo, Spain., Soto-Gordoa M; Faculty of Engineering, Electronics and Computing Department, Mondragon Unibertsitatea, Mondragon, Gipuzkoa, Spain., de Kok I; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Brück C; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Anderson R; Care Policy and Evaluation Centre, London School of Economics, London, England, UK., Pemberton-Ross P; Biogen International GmbH, Baar, Switzerland., Urbich M; Biogen International GmbH, Baar, Switzerland., Jönsson L; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Oct 08. Date of Electronic Publication: 2024 Oct 08.

Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model.

Autor: Leuzy A; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.; Critical Path for Alzheimer's Disease (CPAD) Consortium, Critical Path Institute, Tucson, Arizona, USA.; Enigma Biomedical Group, Knoxville, Tennessee, USA., Raket LL; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.; Eli Lilly and Company, Indianapolis, Indiana, USA., Villemagne VL; Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Florey Department of Neuroscience, University of Melbourne, Parkville, Victoria, Australia.; Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, Victoria, Australia., Klein G; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Tonietto M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Olafson E; Clinical Imaging Group, Genentech, Inc., South San Francisco, California, USA., Baker S; Lawrence Berkeley National Laboratory, Berkeley, California, USA., Saad ZS; Janssen Research & Development, Merryfield Row San Diego, California, USA., Bullich S; Life Molecular Imaging GmbH, Berlin, Germany., Lopresti B; Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Bohorquez SS; Clinical Imaging Group, Genentech, Inc., South San Francisco, California, USA., Boada M; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Av. de Monforte de Lemos, Madrid, Spain., Betthauser TJ; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medicine Division of Geriatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medical Physics, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, Wisconsin, USA., Charil A; Eisai, Inc., Nutley, New Jersey, USA., Collins EC; Eli Lilly and Company, Indianapolis, Indiana, USA., Collins JA; Biogen, Cambridge, Massachusetts, USA., Cullen N; Critical Path for Alzheimer's Disease (CPAD) Consortium, Critical Path Institute, Tucson, Arizona, USA., Gunn RN; Invicro, Hammersmith Hospital, London, UK.; Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK., Higuchi M; Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Inage-ku, Chiba-shi, Chiba, Japan., Hostetler E; Merck & Co., Inc, West Point, Pennsylvania, USA., Hutchison RM; Biogen, Cambridge, Massachusetts, USA., Iaccarino L; Eli Lilly and Company, Indianapolis, Indiana, USA., Insel PS; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, California, USA., Irizarry MC; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA., Jack CR Jr; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA., Jagust WJ; University of California Berkeley, Lawrence Berkeley National Laboratory, Berkeley, California, USA., Johnson KA; Harvard Medical School, Department of Radiology, Boston, Minnesota, USA.; Gordon Center for Medical Imaging, Massachusetts General Hospital, Boston, Minnesota, USA., Johnson SC; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medicine Division of Geriatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medical Physics, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, Wisconsin, USA., Karten Y; Critical Path for Alzheimer's Disease (CPAD) Consortium, Critical Path Institute, Tucson, Arizona, USA., Marquié M; Department of Medicine Division of Geriatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Medical Physics, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, Wisconsin, USA., Mathotaarachchi S; Enigma Biomedical Group, Knoxville, Tennessee, USA., Mintun MA; Eli Lilly and Company, Indianapolis, Indiana, USA., Ossenkoppele R; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.; Amsterdam University Medical Center, Neuroscience Campus Amsterdam, Alzheimercenter, HZ Amsterdam, the Netherlands., Pappas I; Department of Psychology, Helen Wills Neuroscience Institute, University of California, Berkeley, California, USA.; Department of Neurology, VA Northern California Health Care System, Martinez, California, USA., Petersen RC; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Rabinovici GD; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.; Department of Radiology & Biomedical Imaging, University of California, San Francisco, California, USA., Rosa-Neto P; Translational Neuroimaging Laboratory, Department of Neurology and Neurosurgery, Faculty of Medicine, The McGill University Research Centre for Studies in Aging, McGill University, Verdun, Quebec, Canada.; Montreal Neurological Institute, McGill University, Montréal, Québec, Canada., Schwarz CG; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA., Smith R; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.; Department of Neurology, Skåne University Hospital, Lund, Sweden., Stephens AW; Life Molecular Imaging GmbH, Berlin, Germany., Whittington A; Invicro, Hammersmith Hospital, London, UK., Carrillo MC; Alzheimer's Association, Chicago, Illinois, USA., Pontecorvo MJ; Eli Lilly and Company, Indianapolis, Indiana, USA., Haeberlein SB; Enigma Biomedical Group, Knoxville, Tennessee, USA., Dunn B; Senior advisor to CPAD Consortium, Critical Path Institute, Tucson, Arizona, USA., Kolb HC; Enigma Biomedical Group, Knoxville, Tennessee, USA., Sivakumaran S; Critical Path for Alzheimer's Disease (CPAD) Consortium, Critical Path Institute, Tucson, Arizona, USA., Rowe CC; Florey Department of Neuroscience, University of Melbourne, Parkville, Victoria, Australia.; Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, Victoria, Australia.; The Australian Dementia Network (ADNeT), The University of Melbourne, Parkville, Victoria, Australia., Hansson O; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.; Memory Clinic, Skåne University Hospital, Malmö, Sweden., Doré V; Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, Victoria, Australia.; Health and Biosecurity Flagship, The Australian eHealth Research Centre, CSIRO, Parkville, Victoria, Australia.

Publikováno v: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2024 Sep; Vol. 20 (9), pp. 5833-5848. Date of Electronic Publication: 2024 Jul 23.

Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer's disease.

Autor: Jönsson L; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, 171 64, Sweden. Linus.jonsson@ki.se., Ivkovic M; Novo Nordisk A/S, Søborg, Denmark., Atri A; Banner Sun Health Research Institute and Banner Alzheimer's Institute, Banner Health, Sun City and Phoenix, AZ, USA.; Center for Brain/Mind Medicine, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Handels R; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, 171 64, Sweden.; Faculty of Health, Medicine and Life Sciences, School for Mental Health and Neuroscience, Department of Psychiatry and Neuropsychology, Alzheimer Centre Limburg, Maastricht University Medical Centre+, Maastricht, MD, 6200, The Netherlands., Gustavsson A; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, 171 64, Sweden.; Quantify Research, Hantverkargatan 8, Stockholm, 112 21, Sweden., Hahn-Pedersen JH; Novo Nordisk A/S, Søborg, Denmark., León T; Novo Nordisk A/S, Søborg, Denmark., Lilja M; Quantify Research, Hantverkargatan 8, Stockholm, 112 21, Sweden., Gundgaard J; Novo Nordisk A/S, Søborg, Denmark., Raket LL; Novo Nordisk A/S, Søborg, Denmark.; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.

Publikováno v: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Feb 29; Vol. 16 (1), pp. 48. Date of Electronic Publication: 2024 Feb 29.

Predictive value of individual serum neurofilament light chain levels in short-term disease activity in relapsing multiple sclerosis.

Autor: Solís-Tarazona L; Research Group in Immunotherapy and Biomodels for Autoimmunity, Instituto de Investigación Sanitaria La Fe, Valencia, Spain., Raket LL; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden., Cabello-Murgui J; Research Group in Immunotherapy and Biomodels for Autoimmunity, Instituto de Investigación Sanitaria La Fe, Valencia, Spain., Reddam S; Research Group in Immunotherapy and Biomodels for Autoimmunity, Instituto de Investigación Sanitaria La Fe, Valencia, Spain., Navarro-Quevedo S; Neurology, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Gil-Perotin S; Research Group in Immunotherapy and Biomodels for Autoimmunity, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.; Multiple Sclerosis Unit, Neurology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Consorcio Centro de Investigación Biomédica en Red (CIBER), CB06/05/1131, Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: Frontiers in neurology [Front Neurol] 2024 Feb 14; Vol. 15, pp. 1354431. Date of Electronic Publication: 2024 Feb 14 (Print Publication: 2024).

Decision making in clinical trials: Interim analyses, innovative design, and biomarkers.

Autor: Welsh-Bohmer KA; Department of Psychiatry & Neurology Duke University Durham North Carolina USA., Kerchner GA; Pharma Research and Early Development F. Hoffmann-La Roche, Ltd Basel Switzerland., Dhadda S; Eisai Inc. Nutley New Jersey USA., Garcia M; Boehringer Ingelheim Pharmaceuticals Inc. Ridgefield Connecticut USA., Miller DS; Signant Health Blue Bell Pennsylvania USA., Natanegara F; Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana USA., Raket LL; Novo Nordisk A/S Søborg Denmark., Robieson W; AbbVie North Chicago Illinois USA., Siemers ER; ACUMEN Pharmaceuticals Charlottesville Virginia USA., Carrillo MC; Alzheimer's Association Chicago Illinois USA., Weber CJ; Alzheimer's Association Chicago Illinois USA.

Publikováno v: Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2023 Oct 18; Vol. 9 (4), pp. e12421. Date of Electronic Publication: 2023 Oct 18 (Print Publication: 2023).